1 Center for Healthcare Delivery Science and.
2 Division for Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Ann Am Thorac Soc. 2017 Dec;14(12):1803-1809. doi: 10.1513/AnnalsATS.201701-022OC.
Opioid abuse is increasing, but its impact on critical care resources in the United States is unknown.
We hypothesized that there would be a rising need for critical care among opioid-associated overdoses in the United States.
We analyzed all adult admissions, using a retrospective cohort study from 162 hospitals in 44 states, discharged between January 1, 2009, and September 31, 2015 to describe the incidence of intensive care unit (ICU) admissions for opioid overdose during this time. Admissions were identified using the Clinical Database/Resource Manager of Vizient, the successor to the University Health System Consortium.
Our primary outcome was opioid-associated overdose admissions to the ICU. The outcome was defined on the basis of previously validated ICD-9 codes. Our secondary outcomes were in-hospital death and markers of ICU resources. The final cohort included 22,783,628 admissions; 4,145,068 required ICU care. There were 52.4 ICU admissions for overdose per 10,000 ICU admissions over the entire study (95% confidence interval [CI], 51.8-53.0 per 10,000 ICU admissions). During this time period, opioid overdose admissions requiring intensive care increased 34%, from 44 per 10,000 (95% CI, 43-46 per 10,000) to 59 per 10,000 ICU admissions (95% CI, 57-61 per 10,000; P < 0.0001). The mortality rate of patients with ICU admissions with overdoses averaged 7% (95% CI, 7.0-7.6%) but increased to 10% in 2015 (95% CI, 8.8-10.8%).
The number of deaths of ICU patients with opioid overdoses increased substantially in the 7 years of our study, reflecting increases in both the incidence and mortality of this condition. Our findings raise the need for a national approach to developing safe strategies to care for patients with overdose in the ICU, to providing coordinated resources in the hospital for patients and families, and to helping survivors maintain sobriety on discharge.
阿片类药物滥用正在增加,但在美国,其对重症监护资源的影响尚不清楚。
我们假设在美国,与阿片类药物相关的过量用药会导致对重症监护的需求不断增加。
我们分析了来自 44 个州的 162 家医院在 2009 年 1 月 1 日至 2015 年 9 月 31 日期间收治的所有成年患者,以描述在此期间因阿片类药物过量而入住重症监护病房(ICU)的 ICU 入院率。通过维齐恩特(Vizient)的临床数据库/资源管理器(Clinical Database/Resource Manager),即大学健康联盟(University Health System Consortium)的后继者,来识别入院情况。
我们的主要结果是因阿片类药物过量而入住 ICU 的患者人数。根据先前验证过的 ICD-9 编码来定义结果。我们的次要结果是院内死亡和 ICU 资源指标。最终队列包括 22783628 例入院;其中 4145068 例需要 ICU 护理。在整个研究期间,每 10000 例 ICU 入院中有 52.4 例因阿片类药物过量而入院(95%置信区间[CI],每 10000 例 ICU 入院中 51.8-53.0 例)。在此期间,需要重症监护的阿片类药物过量入院人数增加了 34%,从每 10000 例 44 例(95%CI,43-46 例)增加到每 10000 例 59 例(95%CI,57-61 例;P<0.0001)。入住 ICU 的因阿片类药物过量而入院患者的死亡率平均为 7%(95%CI,7.0-7.6%),但在 2015 年上升至 10%(95%CI,8.8-10.8%)。
在我们研究的 7 年中,因 ICU 中阿片类药物过量而死亡的 ICU 患者人数大幅增加,反映出这种疾病的发生率和死亡率都有所增加。我们的研究结果表明,需要采取国家方法制定安全策略,为 ICU 中接受过量药物治疗的患者提供护理,为患者和家属在医院提供协调的资源,并帮助幸存者在出院后保持清醒。